Page 2 - Control Bionics News Today

Share this article MILFORD, Ohio and NEW SOUTH WALES, Australia, April 8, 2021 /PRNewswire/ -- Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering with Numotion, a leading provider of Complex Rehab Technology (CRT) to offer the Control Bionics Trilogy product line. This partnership will expand access those who can benefit from Control Bionics customized Augmentative and Alternative Communication (AAC) solutions. Control ...

This is the latest speculative ASX tech buy from Citigroup Brendon Lau | January 6, 2021 10:46am | More on: Image source: Getty Images If you are on the hunt for the next shooting star in the small-cap tech sector, Citigroup may have just the trick for you. Appetite for such stocks is strong after Brainchip Holdings Ltd(ASX: BRN) share price, Pointerra Ltd(ASX:3DP) share price and Tesserent Ltd(ASX: TNT) shot out the lights in 2020. These stocks gained more than 700% ov...

Citi have retained their buy rating and $24.00 price target on this investment platform provider’s shares. The broker points out that the company has signed an agreement with IOOF Holdings Limited (ASX: IFL). While it sees some risks from the deal, overall it views it as a positive. In addition to this, the broker believes HUB24 is well-placed to benefit from the ongoing structural shift in wealth management. The HUB24 share price is changing hands for $20.82 on Thursday. A note out of Mor...